Hypofractionation for prostate cancer radiotherapy—what are the issues? (Q79202286)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14575821%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

Hypofractionation for prostate cancer radiotherapy--what are the issues? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14575821%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Hypofractionation for prostate cancer radiotherapy—what are the issues? (English)

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)01456-1

24 March 2024

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14575821

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)01456-1

24 March 2024

author name string

David J. Brenner

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14575821

24 March 2024

language of work or name

English

0 references

publication date

1 November 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14575821%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

15 November 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14575821

full work available at URL

24 March 2024

https://api.elsevier.com/content/article/PII:S0360301603014561?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)01456-1

https://api.elsevier.com/content/article/PII:S0360301603014561?httpAccept=text/plain

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)01456-1

International Journal of Radiation Oncology Biology Physics

24 March 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14575821%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14575821%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14575821%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

912-914

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14575821%20AND%20SRC:MED&resulttype=core&format=json

Fractionation and protraction for radiotherapy of prostate carcinoma

20 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901456-1

7 January 2021

Is the prostrate alpha/beta ratio of 1.5 from Brenner & Hall a modeling artifact

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901456-1

7 January 2021

Toward optimal external-beam fractionation for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901456-1

7 January 2021

Is alpha/beta for prostate tumors really low?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901456-1

7 January 2021

Hypofractionation for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901456-1

7 January 2021

A simple analytic derivation suggests that prostate cancer alpha/beta ratio is low

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901456-1

7 January 2021

Is the alpha/beta ratio for prostate cancer low?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901456-1

7 January 2021

Yes, the alpha/beta ratio for prostate cancer is low or "methinks the lady doth protest too much...about a low alpha/beta that is"

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901456-1

7 January 2021

Is the alpha/beta for prostate tumors really low? In regard to Fowler et al., IJROBP 2001;50:1021-1031.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901456-1

7 January 2021

Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901456-1

7 January 2021

In regard to Brenner et al. Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio) similar to late-responding normal tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901456-1

7 January 2021

How low is the alpha/beta ratio for prostate cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901456-1

7 January 2021

Prediction of the benefits from dose-escalated hypofractionated intensity-modulated radiotherapy for prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901456-1

7 January 2021

The influence of brachytherapy dose heterogeneity on estimates of / for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901456-1

7 January 2021

Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: implications for the alpha/beta ratio.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901456-1

7 January 2021

How low is the α/β ratio for prostate cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901456-1

7 January 2021

Cell kinetic measurements in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901456-1

7 January 2021

RBE values and repair characteristics for colo-rectal injury after caesium 137 gamma-ray and neutron irradiation. II. Fractionation up to ten doses

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901456-1

7 January 2021

Radiation tolerance of the rat rectum to fractionated X-rays and pi-mesons

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901456-1

7 January 2021

The effect of cis-diamminedichloroplatinum(II) on radiation damage in mouse rectum after fractionated irradiation.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901456-1

7 January 2021

Early and late injuries in mouse rectum after fractionated X-ray and neutron irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901456-1

7 January 2021

Chronic radiation damage in the rat rectum: an analysis of the influences of fractionation, time and volume.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901456-1

7 January 2021

Sublethal damage repair times for a late-responding tissue relevant to brachytherapy (and external-beam radiotherapy): implications for new brachytherapy protocols

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901456-1

7 January 2021

Radiation-induced rectal complications are not influenced by age: a dose fractionation study in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901456-1

7 January 2021

The correlation of acute toxicity and late rectal injury in radiotherapy for cervical carcinoma: evidence suggestive of consequential late effect (CQLE)

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901456-1

7 January 2021

Consequential late effects in normal tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901456-1

7 January 2021

Relationship between acute and late normal tissue injury after postoperative radiotherapy in endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901456-1

7 January 2021

Dangers of the clinical use of the NSD formula for small fraction numbers

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901456-1

7 January 2021

Morbidity from large dose fractions in radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901456-1

7 January 2021

Myelopathy following radiotherapy of bronchial carcinoma with large single fractions: a retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901456-1

7 January 2021

Large-dose fractionation (hypofractionation).

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901456-1

7 January 2021

Radical external beam radiotherapy for localised carcinoma of the prostate using a hypofractionation technique

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901456-1

7 January 2021

What hypofractionated protocols should be tested for prostate cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901456-1

7 January 2021

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14575821%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference